Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain

Breast cancer is one of the most frequent malignancies. The aim of the article is to analyse the cost-utility ratio and budgetary impact of talazoparib treatment for patients with locally advanced or metastatic gBRCA + breast cancer from the perspective of the Spanish National Health System. Analyse...

Descripción completa

Detalles Bibliográficos
Autores principales: Olry de Labry Lima, Antonio, Špacírová, Zuzana, Fénix-Caballero, Silvia, Hoces, Antonio Matas, Vegas, Adrián Sánchez, Aranzana, Manuel Cárdenas, Sierra-Sánchez, Jesús F., Díaz, María del Carmen Martínez, Alegre del Rey, Emilio Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099594/
https://www.ncbi.nlm.nih.gov/pubmed/33895483
http://dx.doi.org/10.1016/j.breast.2021.04.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099594/
https://www.ncbi.nlm.nih.gov/pubmed/33895483
http://dx.doi.org/10.1016/j.breast.2021.04.004

Ejemplares similares